161 related articles for article (PubMed ID: 12224506)
21. Clinical-scale isolation of 'minimally manipulated' cytomegalovirus-specific donor lymphocytes for the treatment of refractory cytomegalovirus disease.
Odendahl M; Grigoleit GU; Bönig H; Neuenhahn M; Albrecht J; Anderl F; Germeroth L; Schmitz M; Bornhäuser M; Einsele H; Seifried E; Busch DH; Tonn T
Cytotherapy; 2014 Sep; 16(9):1245-56. PubMed ID: 25108651
[TBL] [Abstract][Full Text] [Related]
22. Increased expression of leukocyte Ig-like receptor-1 and activating role of UL18 in the response to cytomegalovirus infection.
Wagner CS; Riise GC; Bergström T; Kärre K; Carbone E; Berg L
J Immunol; 2007 Mar; 178(6):3536-43. PubMed ID: 17339449
[TBL] [Abstract][Full Text] [Related]
23. Cytomegalovirus (CMV)-specific cellular immune responses.
Harari A; Zimmerli SC; Pantaleo G
Hum Immunol; 2004 May; 65(5):500-6. PubMed ID: 15172450
[TBL] [Abstract][Full Text] [Related]
24. A survival game of hide and seek: cytomegaloviruses and MHC class I antigen presentation pathways.
Basta S; Bennink JR
Viral Immunol; 2003; 16(3):231-42. PubMed ID: 14583141
[TBL] [Abstract][Full Text] [Related]
25. Human cytomegalovirus immunity and immune evasion.
Jackson SE; Mason GM; Wills MR
Virus Res; 2011 May; 157(2):151-60. PubMed ID: 21056604
[TBL] [Abstract][Full Text] [Related]
26. How the virus outsmarts the host: function and structure of cytomegalovirus MHC-I-like molecules in the evasion of natural killer cell surveillance.
Revilleza MJ; Wang R; Mans J; Hong M; Natarajan K; Margulies DH
J Biomed Biotechnol; 2011; 2011():724607. PubMed ID: 21765638
[TBL] [Abstract][Full Text] [Related]
27. A role for MHC class I down-regulation in NK cell lysis of herpes virus-infected cells.
Huard B; Früh K
Eur J Immunol; 2000 Feb; 30(2):509-15. PubMed ID: 10671206
[TBL] [Abstract][Full Text] [Related]
28. The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells.
Reyburn HT; Mandelboim O; Valés-Gómez M; Davis DM; Pazmany L; Strominger JL
Nature; 1997 Apr; 386(6624):514-7. PubMed ID: 9087413
[TBL] [Abstract][Full Text] [Related]
29. Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion.
Mocarski ES
Trends Microbiol; 2002 Jul; 10(7):332-9. PubMed ID: 12110212
[TBL] [Abstract][Full Text] [Related]
30. Fatal attraction: cytomegalovirus-encoded chemokine homologs.
Saederup N; Mocarski ES
Curr Top Microbiol Immunol; 2002; 269():235-56. PubMed ID: 12224512
[TBL] [Abstract][Full Text] [Related]
31. CMV and natural killer cells: shaping the response to vaccination.
Goodier MR; Jonjić S; Riley EM; Juranić Lisnić V
Eur J Immunol; 2018 Jan; 48(1):50-65. PubMed ID: 28960320
[TBL] [Abstract][Full Text] [Related]
32. Cytomegalovirus encodes a positive regulator of antigen presentation.
Holtappels R; Gillert-Marien D; Thomas D; Podlech J; Deegen P; Herter S; Oehrlein-Karpi SA; Strand D; Wagner M; Reddehase MJ
J Virol; 2006 Aug; 80(15):7613-24. PubMed ID: 16840340
[TBL] [Abstract][Full Text] [Related]
33. Cytomegalovirus and transcriptional down-regulation of major histocompatibility complex class II expression.
Miller DM; Cebulla CM; Rahill BM; Sedmak DD
Semin Immunol; 2001 Feb; 13(1):11-8. PubMed ID: 11289795
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of NK cells by murine CMV-encoded class I MHC homologue m144.
Kubota A; Kubota S; Farrell HE; Davis-Poynter N; Takei F
Cell Immunol; 1999 Feb; 191(2):145-51. PubMed ID: 9973537
[TBL] [Abstract][Full Text] [Related]
35. Human leukocyte antigen E in human cytomegalovirus infection: friend or foe?
Gong F; Song S; Lv G; Pan Y; Zhang D; Jiang H
Acta Biochim Biophys Sin (Shanghai); 2012 Jul; 44(7):551-4. PubMed ID: 22576308
[TBL] [Abstract][Full Text] [Related]
36. Assessment of cellular immunity to human cytomegalovirus in recipients of allogeneic stem cell transplants.
Lacey SF; Diamond DJ; Zaia JA
Biol Blood Marrow Transplant; 2004 Jul; 10(7):433-47. PubMed ID: 15205665
[TBL] [Abstract][Full Text] [Related]
37. Cytomegalovirus immune evasion.
Powers C; DeFilippis V; Malouli D; Früh K
Curr Top Microbiol Immunol; 2008; 325():333-59. PubMed ID: 18637515
[TBL] [Abstract][Full Text] [Related]
38. HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes.
Romagnani C; Pietra G; Falco M; Mazzarino P; Moretta L; Mingari MC
Hum Immunol; 2004 May; 65(5):437-45. PubMed ID: 15172443
[TBL] [Abstract][Full Text] [Related]
39. The putative natural killer decoy early gene m04 (gp34) of murine cytomegalovirus encodes an antigenic peptide recognized by protective antiviral CD8 T cells.
Holtappels R; Thomas D; Podlech J; Geginat G; Steffens HP; Reddehase MJ
J Virol; 2000 Feb; 74(4):1871-84. PubMed ID: 10644360
[TBL] [Abstract][Full Text] [Related]
40. Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells.
Groh V; Rhinehart R; Randolph-Habecker J; Topp MS; Riddell SR; Spies T
Nat Immunol; 2001 Mar; 2(3):255-60. PubMed ID: 11224526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
